United States
Germany
Japan
United Kingdom
China
Faslg (Myc-DDK-tagged ORF) - Rat Fas ligand (TNF superfamily, member 6) (Faslg), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
Fas Ligand Rabbit polyclonal Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse |
CD178 / Fas Ligand (His-tag) human recombinant protein, 10 µg
| Tag | His-tag |
| Expression Host | CHO |
Fas Ligand (FASLG) mouse monoclonal antibody, clone NOK-1, Purified
| Applications | FC, FN, IF, IP, WB |
| Reactivities | Human |
AM26762PU-N is a replacement of TA320328.
Fas Ligand (FASLG) mouse monoclonal antibody, clone 1OF2, Purified
| Applications | ELISA, FC, IP |
| Reactivities | Human |
Fas Ligand (FASLG) mouse monoclonal antibody, clone 14C2, Purified
| Applications | ELISA, FC, IP |
| Reactivities | Human |
Fas Ligand (FASLG) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
Fas Ligand (FASLG) rabbit polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
Lenti ORF clone of Faslg (mGFP-tagged ORF) - Rat Fas ligand (TNF superfamily, member 6) (Faslg), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Faslg (Myc-DDK-tagged ORF) - Rat Fas ligand (TNF superfamily, member 6) (Faslg), (10 ug)
| Type | Rat Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
qSTAR qPCR primer pairs against Homo sapiens gene FASLG
CD178 polyclonal antibody
| Applications | WB |
| Reactivities | Human |
Fas Ligand (FASLG) mouse monoclonal antibody, clone NOK-1, PE
| Applications | FC |
| Reactivities | Human |
CD178 polyclonal antibody
| Applications | WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Conjugates
Clonalities
Mutants
Assay Types
Brands
Pathways
- Allograft rejection (3)
- Apoptosis (3)
- Autoimmune thyroid disease (3)
- Cytokine-cytokine receptor interaction (3)
- Graft-versus-host disease (3)
- MAPK signaling pathway (3)
- Natural killer cell mediated cytotoxicity (3)
- Neurotrophin signaling pathway (3)
- Pathways in cancer (3)
- Type I diabetes mellitus (3)
